Insider Transactions in Q2 2018 at Eli Lilly & CO (LLY)
Insider Transaction List (Q2 2018)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 18
2018
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
127
+0.31%
|
$10,922
$86.11 P/Share
|
|
Jun 18
2018
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
63
+0.11%
|
$5,418
$86.11 P/Share
|
|
Jun 18
2018
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
112
+1.8%
|
$9,632
$86.11 P/Share
|
|
Jun 15
2018
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
180,000
-0.15%
|
$15,480,000
$86.65 P/Share
|
|
Jun 14
2018
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
107,698
-0.09%
|
$9,262,028
$86.31 P/Share
|
|
Jun 14
2018
|
Daniel Skovronsky EVP, CSO & Pres. LRL & LLY Imm |
BUY
Open market or private purchase
|
Direct |
10,000
+15.34%
|
$860,000
$86.22 P/Share
|
|
Jun 13
2018
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
11,104
-0.01%
|
$954,944
$86.27 P/Share
|
|
Jun 11
2018
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
51,198
-0.04%
|
$4,403,028
$86.38 P/Share
|
|
Jun 04
2018
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
135,478
-0.11%
|
$11,515,630
$85.12 P/Share
|
|
Jun 01
2018
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
39,522
-0.03%
|
$3,359,370
$85.31 P/Share
|
|
May 31
2018
|
Enrique A Conterno SVP&Pres, LillyDiab & LillyUSA |
SELL
Open market or private sale
|
Direct |
25,000
-16.72%
|
$2,125,000
$85.0 P/Share
|
|
May 30
2018
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
180,000
-0.15%
|
$14,940,000
$83.85 P/Share
|
|
May 29
2018
|
Christi Shaw SVP and Pres., Lilly Bio-Meds |
SELL
Open market or private sale
|
Direct |
8,426
-100.0%
|
$690,932
$82.1 P/Share
|
|
May 21
2018
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
133
+0.33%
|
$10,773
$81.83 P/Share
|
|
May 21
2018
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
67
+0.11%
|
$5,427
$81.83 P/Share
|
|
May 21
2018
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
118
+1.94%
|
$9,558
$81.83 P/Share
|
|
May 11
2018
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
140,000
-0.11%
|
$11,340,000
$81.97 P/Share
|
|
May 03
2018
|
Jeffrey N Simmons SVP&Pres. Elanco Animal Health |
SELL
Open market or private sale
|
Direct |
9,027
-6.25%
|
$704,106
$78.5 P/Share
|
|
May 01
2018
|
Enrique A Conterno SVP&Pres, LillyDiab & LillyUSA |
SELL
Payment of exercise price or tax liability
|
Direct |
8,934
-5.64%
|
$723,654
$81.07 P/Share
|
|
May 01
2018
|
Enrique A Conterno SVP&Pres, LillyDiab & LillyUSA |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+11.21%
|
-
|
|
May 01
2018
|
Christi Shaw SVP and Pres., Lilly Bio-Meds |
SELL
Payment of exercise price or tax liability
|
Direct |
5,324
-38.72%
|
$431,244
$81.07 P/Share
|
|
May 01
2018
|
Christi Shaw SVP and Pres., Lilly Bio-Meds |
BUY
Exercise of conversion of derivative security
|
Direct |
13,750
+50.0%
|
-
|
|
May 01
2018
|
Jeffrey N Simmons SVP&Pres. Elanco Animal Health |
SELL
Payment of exercise price or tax liability
|
Direct |
8,716
-5.69%
|
$705,996
$81.07 P/Share
|
|
May 01
2018
|
Jeffrey N Simmons SVP&Pres. Elanco Animal Health |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+11.55%
|
-
|
|
Apr 25
2018
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
180,000
-0.07%
|
$14,580,000
$81.21 P/Share
|
|
Apr 16
2018
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
136
+0.34%
|
$10,880
$80.12 P/Share
|
|
Apr 16
2018
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
68
+0.12%
|
$5,440
$80.12 P/Share
|
|
Apr 16
2018
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
121
+2.03%
|
$9,680
$80.12 P/Share
|
|
Apr 16
2018
|
Susan Mahony SVP & Pres., Lilly Oncology |
SELL
Open market or private sale
|
Direct |
17,379
-38.07%
|
$1,390,320
$80.08 P/Share
|
|
Apr 13
2018
|
Susan Mahony SVP & Pres., Lilly Oncology |
SELL
Open market or private sale
|
Direct |
5,165
-10.16%
|
$413,200
$80.14 P/Share
|